John D. Quisel - 28 Nov 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
28 Nov 2023
Transactions value $
$0
Form type
4
Filing time
29 Nov 2023, 18:38:12 UTC
Previous filing
03 Jan 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +230K $0.00 230K 28 Nov 2023 Common Stock 230K $0.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.